This week, we’ll be rounding up 5 of the most impactful tweets in Life Sciences, to keep you in the loop.
May 19, 2017 | by Kathy Manta
Adam Rogers, editor at WIRED shares an interview he had with Tom Insel, neuroscientist and the former director at the National Institute for Mental Health. The interview was regarding Insel’s decision to start up his own company, Mindstrong, that attempts to develop technology to diagnose and treat mental disorders.
The Royal Society celebrated Dorothy Hodgkin FRS’ birthday on May 12. Hodgkin’s remarkable work in chemistry lead to her winning the Nobel Prize in 1954 for the development of protein crystallography.
The Lancet publishes research done by The Woman Trial collaborators. The study found that administration of tranexamic acid was able to significantly decrease the number of maternal deaths due to postpartum haemorrhage. There appears to be no adverse side effects from the treatment.
Antonio Regalado, writer for the MIT Technology Review, shares inaccurate article describing the current use of CRISPR technology to prevent the spread of disease and solve global famine. CRISPR is used to edit genes.
Frank David, the biotech advisor at Pharmagellan debunks the myth that pharma companies aren’t allocating enough money towards research and development. He shows that overtime the research and development growth in funding supasses that of SG&A (sales, general and administrative) and revenue.
Keywords: Life Science, Pharma, CRISPR
NEXT ARTICLE | MORE BLOG POSTS | NEWS | VIDEOS | POLLS & QUIZZES | WEBINARS |